White label – Pompe disease - ClinicalTrials.eu

Study on the Effects of Vidofludimus Calcium for Patients with Post-COVID Syndrome

Not recruiting

2 1
Investigated Diseases:
- Post-acute COVID-19 syndrome
Investigated Drugs:
- Vidofludimus Calcium
Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

Not recruiting

2 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Acp-204 Tartrate
Study on Bendamustine, Obinutuzumab, Zanubrutinib, and Venetoclax for Patients with Relapsed Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
Study on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study

Not recruiting

4 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- Spesolimab
+8
Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Atl001
- Pembrolizumab
Study on the Safety and Feasibility of Oral Zinc Acetate Dihydrate for Patients with GNAO1-Related Disorders

Not recruiting

2 1 1 1
Investigated Diseases:
- Neurodevelopmental disorder
Investigated Drugs:
- Zinc Acetate Dihydrate
Study on Lisocabtagene Maraleucel for Adults with Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma

Not recruiting

2 1 1
Investigated Diseases:
- B-cell lymphoma
Investigated Drugs:
- Lisocabtagene Maraleucel
Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

Not recruiting

3 1 1
Investigated Drugs:
+6
Comparison of oral versus intravenous paracetamol and ibuprofen for pain relief after knee arthroscopy

Not recruiting

3 1 1
Investigated Drugs:
Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Marginal zone lymphoma
Investigated Drugs:
- Ibrutinib
- Rituximab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies